FUNDAMENTALS · Fundamentals · TH Healthcare

Bumrungrad Hospital Public (BH) Fundamentals 2026 — P/E 19.1x, Revenue Analysis | SniperIQ

Bumrungrad Hospital Public (BH) is a TH-listed Healthcare company in Medical - Care Facilities with a market capitalization of ฿144.3B, trading at ฿181.50 on the SET. This SniperIQ fundamentals page covers Bumrungrad Hospital Public's valuation (P/E 19.1x, P/B 4.5x), profitability (net margin 30.0%), revenue (฿25.1B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market Cap฿144.3B
P/E (TTM)19.1x
Net Margin30.0%
Revenue (FY25)฿25.1B

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is Bumrungrad Hospital Public's market cap?

Bumrungrad Hospital Public (BH) has a market capitalization of approximately ฿144.3B, trading at ฿181.50 on the SET. Market cap moves with the live share price.

What is Bumrungrad Hospital Public's P/E ratio?

Bumrungrad Hospital Public's trailing twelve-month P/E ratio is 19.1x, with a price-to-book (P/B) of 4.5x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is Bumrungrad Hospital Public?

Bumrungrad Hospital Public runs a net profit margin of 30.0%, a gross margin of 52.0%, and an operating margin of 34.9%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Bumrungrad Hospital Public generate?

Bumrungrad Hospital Public reported revenue of ฿25.1B for fiscal year 2025, with net income of ฿7.5B and earnings per share (EPS) of 9.45. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Bumrungrad Hospital Public pay a dividend?

Bumrungrad Hospital Public offers a trailing dividend yield of about 6.1%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.

Is Bumrungrad Hospital Public financially healthy?

Bumrungrad Hospital Public carries a debt-to-equity ratio of 0.01x and a current ratio of 4.48x, with a market beta of 0.22. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Bumrungrad Hospital Public a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Bumrungrad Hospital Public (BH) the key facts are: market cap ฿144.3B, P/E 19.1x, revenue ฿25.1B, 52-week range 136-214. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track Bumrungrad Hospital Public's full fundamentals live

Get Bumrungrad Hospital Public's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.

Related: Ilsung Is (003120) fundamentals · Jeil Pharmaceutical (271980) fundamentals · Kaken Pharmaceutical (4521) fundamentals · Pfizer (PFE) fundamentals · All stock fundamentals · AI signal library
Research Hubs: Fundamentals library · Screeners · Institutional positioning · Super investors · Daily signals · Platform comparisons